Analyst price target range
Quince Therapeutics Price Target: $77.20 Average
Direct answer
Quince Therapeutics's average price target is $77.20.
The verified analyst range runs from $68.00 to $98.00.
The low target implies +132.1%, the high target implies +234.5%, and the range spans 102.4% of the current price.
Forecast evidence checked September 18, 2026.
Get free Quince Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $29.30
- Average price target
- $77.20
- High price target
- $98.00
- Low price target
- $68.00
- Low target gap
- +132.1%
- Target upside
- +163.5%
- High target gap
- +234.5%
- Target range width
- 102.4%
- Consensus rating
- Buy
- Analysts
- 5
- Evidence date
- September 18, 2026
- Valid through
- September 25, 2026
Explore related company data
Read the frequently asked questions.
What is Quince Therapeutics's average price target?
Quince Therapeutics's verified average price target is $77.20. The target range is $68.00 to $98.00.
How far are Quince Therapeutics's low and high targets from the recorded price?
The low target implies +132.1%, while the high target implies +234.5%.
How many analysts are included in Quince Therapeutics's consensus?
The verified consensus includes 5 analysts.
How is Quince Therapeutics's target upside or downside calculated?
The average target of $77.20 is divided by the recorded price of $29.30, then one is subtracted to produce +163.5%. This does not guarantee a future return.
When was Quince Therapeutics's analyst forecast verified?
The data was verified on 2026-09-18. The dataset is valid through 2026-09-25.